Several studies have shown that PTL therapy can cause intrinsic or extrinsic apoptosis in tumor cells by activating the p53 signaling route, regulating the Bcl-2 family members, blocking the activities of the NF-κB signaling pathways, and producing reactive oxygen species [140]. Here, TP53 is linked to neoplasm.